Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs)

Thorax

Volumn 70, Issue 5, 2015, Pages 451-457

  Martineau, Adrian R ^a   MacLaughlin, Beverley D ^a   Hooper, Richard L ^a   Barnes, Neil C ^a   Jolliffe, David A ^a   Greiller, Claire L ^a   Kilpin, Kate ^a   McLaughlin, David ^a   Fletcher, Gareth ^a   Mein, Charles A ^a   Hoti, Mimoza ^a   Walton, Robert ^a   Grigg, Jonathan ^a   Timms, Peter M ^b   Rajakulasingam, Raj K ^b   Bhowmik, Angshu ^b   Rowe, Marion ^b   Venton, Timothy R ^b   Choudhury, Aklak B ^c   Simcock, David E ^d   Sadique, Zia ^e   Monteiro, William R ^f   Corrigan, Christopher J ^g   Hawrylowicz, Catherine M ^g   Griffiths, Christopher J ^a,g   more..

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b HOMERTON UNIVERSITY HOSPITAL   (United Kingdom)

^c QUEEN S HOSPITAL   (United Kingdom)

^d ROYAL LONDON HOSPITAL   (United Kingdom)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f GLENFIELD HOSPITAL   (United Kingdom)

^g KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; COLECALCIFEROL; CORTICOSTEROID; LONG ACTING DRUG; PLACEBO; VITAMIN D; VITAMIN;

ADULT; AGED; ARTICLE; ASTHMA; CONTROLLED STUDY; DISEASE EXACERBATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; FRACTIONAL EXHALED NITRIC OXIDE; GENOTYPE; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY TRACT PARAMETERS; SINGLE NUCLEOTIDE POLYMORPHISM; ST. GEORGE RESPIRATORY QUESTIONNAIRE; TREATMENT OUTCOME; UNITED KINGDOM; UPPER RESPIRATORY TRACT INFECTION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; COHORT ANALYSIS; COMPLICATION; DIET SUPPLEMENTATION; DRUG ADMINISTRATION; INCIDENCE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTIONS; TIME;

ADULT; ASTHMA; CHOLECALCIFEROL; COHORT STUDIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RESPIRATORY TRACT INFECTIONS; TIME FACTORS; VITAMINS;

EID: 84929462409     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2014-206449     Document Type: Article

References (29)

1. Jackson DJ, Sykes A, Mallia P, et al. Asthma exacerbations: origin, effect, and prevention. J Allergy Clin Immunol 2011;128:1165-74.
2. Jolliffe DA, Griffiths CJ, Martineau AR. Vitamin D in the prevention of acute respiratory infection: systematic review of clinical studies. J Steroid Biochem Mol Biol 2013;136:321-9.
3. Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 2009;169:384-90.
4. Hansdottir S, Monick MM, Lovan N, et al. Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state. J Immunol 2010;184:965-74.
5. Xystrakis E, Kusumakar S, Boswell S, et al. Reversing the defective induction of L-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest 2006;116:146-55.
6. Majak P, Olszowiec-Chlebna M, Smejda K, et al. Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. J Allergy Clin Immunol 2011;127:1294-6.
7. Yadav M, Mittal K. Effect of vitamin D supplementation on moderate to severe bronchial asthma. Indian J Pediatr 2014;81:650-4.
8. 3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA 2014;311:2083-91.
9. Du R, Litonjua AA, Tantisira KG, et al. Genome-wide association study reveals class MHC-restricted T cell-associated molecule gene (CRTAM) variants interact with vitamin D levels to affect asthma exacerbations. J Allergy Clin Immunol 2012;129:368-73, 73.e1-5.
10. Jones PW, Quirk FH, Baveystock CM, et al. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145:1321-7.
11. EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.
12. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004;113:59-65.
13. O'Byrne PM, Barnes PJ, Rodriguez-Roisin R, et al. Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med 2001;164(8 Pt 1):1392-7.
14. Payne L, Kuhlmann-Berenzon S, Ekdahl K, et al. 'Did you have flu last week?' A telephone survey to estimate a point prevalence of influenza in the Swedish population. Euro Surveill 2005;10:241-4.
15. Jackson GG, Dowling HF, Spiesman IG, et al. Transmission of the common cold to volunteers under controlled conditions. I. The common cold as a clinical entity. Arch Intern Med 1958;101:267-78.
16. Griffiths C, Foster G, Barnes N, et al. Specialist nurse intervention to reduce unscheduled asthma care in a deprived multiethnic area: the east London randomised controlled trial for high risk asthma (ELECTRA). BMJ 2004;328:144.
17. Schoenfeld DA, Richter JR. Nomograms for calculating the number of patients needed for a clinical trial with survival as an endpoint. Biometrics 1982;38:163-70.
18. Jones PW. St. George's Respiratory Questionnaire: MCID. COPD 2005;2:75-9.
19. Pfeifer M, Begerow B, Minne HW. Vitamin D and muscle function. Osteoporos Int 2002;13:187-94.
20. Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Washington DC: National Academy Press, 2011.
21. Martineau AR, Hanifa Y, Hooper RL, et al. Increased risk of upper respiratory infection with addition of intermittent bolus-dose vitamin D supplementation to a daily low-dose regimen. Thorax 2013;68(Suppl 3):A64.
22. Nicholson KG, Kent J, Irelnad DC. Respiratory viruses and exacerbations of asthma in adults. Br Med J 1993;307:982-6.
23. Ilahi M, Armas LA, Heaney RP. Pharmacokinetics of a single, large dose of cholecalciferol. Am J Clin Nutr 2008;87:688-91.
24. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003;326:469.
25. Vieth R. How to optimize vitamin D supplementation to prevent cancer, based on cellular adaptation and hydroxylase enzymology. Anticancer Res 2009;29:3675-84.
26. Hollis BW, Wagner CL. The role of the parent compound vitamin D with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes. J Clin Endocrinol Metab 2013;98:4619-28.
27. Martineau AR, Wilkinson RJ, Wilkinson KA, et al. A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med 2007;176:208-13.
28. Martineau AR, James WY, Hooper RL, et al. Vitamin D supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial. Lancet Respir Med 2015;3:120-30.
29. Lehouck A, Mathieu C, Carremans C, et al. High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2012;156:105-14.